Drug Profile
SF 1019
Alternative Names: R-1818; SF-1019Latest Information Update: 10 Apr 2015
Price :
$50
*
At a glance
- Originator Argyll Biotechnologies LLC
- Developer Argyll Biotechnologies
- Class Anti-inflammatories; Lipoproteins; Non-opioid analgesics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Registered Diabetic neuropathies; Inflammation; Skin ulcer
Most Recent Events
- 13 Aug 2008 Registered for Diabetic neuropathies in Malaysia (SC)
- 13 Aug 2008 Registered for Inflammation in Malaysia (SC)
- 13 Aug 2008 Registered for Skin ulcer in Malaysia (SC)